BIRC5 expression by race, age and clinical factors in breast cancer patients

Alina M. Hamilton,Andrea Walens,Sarah C. Van Alsten,Linnea T. Olsson,Joseph Nsonwu-Farley,Xiaohua Gao,Erin L. Kirk,Charles M. Perou,Lisa A. Carey,Melissa A. Troester,Yara Abdou
DOI: https://doi.org/10.1186/s13058-024-01792-y
2024-03-23
Breast Cancer Research
Abstract:Survivin/BIRC5 is a proliferation marker that is associated with poor prognosis in breast cancer and an attractive therapeutic target. However, BIRC5 has not been well studied among racially diverse populations where aggressive breast cancers are prevalent.
oncology
What problem does this paper attempt to address?